EquityZen Growth Technology Fund LLC - Series 149
Raised
$810K
Investors
37
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 149 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and managed by Assure Fund Management II LLC. This amended filing reports $810K raised from 37 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. It is part of the EquityZen platform, which sponsors pre-IPO secondary market access vehicles across 1,891 related EDGAR entities.
This pre-IPO pooled fund uses the standard 506(b) / 3(c)(1) exemption structure common to retail-accessible secondary market vehicles. The $10K minimum and $21.9K average investor commitment are consistent with EquityZen's model of fractionalizing access to late-stage private company shares, positioned at the lower end of the alternative investment minimum spectrum.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Erin Rosenthal
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
